Tranexamic acid decreases blood loss during transurethral resection of the prostate (TUR-P)

Central European Journal of Urology

Volumn 64, Issue 3, 2011, Pages 156-158

  Kumsar, Şükrü ^a   Dirim, Ayhan ^b   Toksöz, Serdar ^b   Saǧlam, Hasan S ^c   Adsan, Öztuǧ ^c  

^a Sakarya Training and Research Hospital   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c SAKARYA UNIVERSITY   (Turkey)

Author keywords

Prostate; Prostatic hyperplasia; Tranexamic acid; Transurethral resection of the prostate

Indexed keywords

EID: 80052421398     PISSN: 20804806     EISSN: 20804873     Source Type: Journal    
DOI: 10.5173/ceju.2011.03.art13     Document Type: Article

References (17)

1. Meigs JB, Mohr B, Barry MJ, et al: Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clinical Epidemiology 2011; 54: 935-944.
2. Borboroglu PG, Kane CJ, Ward JF, et al: Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999; 162: 1307-1310.
3. Erstad BL: Systemic hemostatic medications for reducing surgical blood loss. Ann Pharmacother 2001; 35: 925-934.
4. Nielsen JD, Gram J, Fabrin A, et al: Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate. Br J Urol 1997; 80: 105-110.
5. Mannucci PM: Hemostatic drugs. N Engl J Med 1998; 339: 245-253.
6. Madsen PO, Strauch AE: The effect of aminocaproic acid on bleeding following transurethral prostatectomy. J Urol 1966; 96: 255-256.
7. Sharifi R, Lee M, Ray P, et al: Safety and efficacy of intravesical aminocaproic acid for bleeding after transurethral resection of prostate. Urology 1986; 27: 214-219.
8. Miller RA, May MW, Hendry WF, et al: The prevention of secondary haemorrhage after prostatectomy: the value of antifibrinolytic therapy. Br J Urol 1980; 52: 26-28.
9. Rannikko A, Petas A, Taari K: Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy. Urology 2004; 64: 955-958.
10. Ekengren JC, Hohn RG: Blood loss during transurethral resection of the prostate as measured with the Hemocue photometer. Scand J Urol Neph 1993; 27: 501-507.
11. Donohue JF, Sharma H, Abraham R, et al: Transurethral prostate resection and bleeding: a randomized, placebo controlled trial of the role of finasteride for decreasing operative blood loss. J Urol 2002; 168: 2024-2026.
12. Hagerty JA, Ginsberg JD, Harmon JD, et al: Pretreatment with finasteride decreases perioperative bleeding associated with transurethral resection of the prostate. Urology 2000; 55: 684-689.
13. Sandfeldt L, Bailey DM, Hahn RG: Blood loss during transurethral resection of the prostate after 3 months of treatment with finasteride. Urology 2001; 58: 972-976.
14. Puchner PJ, Miller MI: The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report. J Urol 1995; 154: 1779-1782.
15. Hahn RG, and Ekengren JC: Patterns of irrigating fluid absorption during transurethral resection of the prostate as indicated by ethanol. J Urol 1993; 149: 502-506.
16. Berntorp E, Follrud C, Lethagen S: No increased risk of venous thrombosis in women taking tranexamic acid. Thromb Haemost 2001; 86: 714-715.
17. Ruel MA, Wang F, Bourke ME, et al: Is tranexamic acid safe in patients undergoing coronary endarterectomy? Ann Thorac Surg 2001; 71: 1508-1511.